+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Recent advances in targeted anti-vasculature therapy: the neuroblastoma model



Recent advances in targeted anti-vasculature therapy: the neuroblastoma model



Current Drug Targets 10(10): 1021-1027



Novel anti-vasculature strategies that are emerging for the treatment of cancer and for the inhibition of angiogenesis may be a promising new tool for the adjuvant therapy of malignant tumours. Over the last fifteen years, several reports have been published concerning the relationship between tumour progression and angiogenesis in experimental models of neuroblastoma in vitro and in vivo. Moreover, a high vascular index in neuroblastoma correlates with poor prognosis, suggesting dependence of aggressive tumour growth on active angiogenesis. Here, we present an overview of the most recent advances in anti-vasculature therapy of neuroblastoma, and describe some preclinical results as well as future perspectives.

(PDF emailed within 1 workday: $29.90)

Accession: 055398721

Download citation: RISBibTeXText

PMID: 19663770


Related references

Recent Advances and Strategies in Tumor Vasculature Targeted Nano-Drug Delivery Systems. Current Pharmaceutical Design 21(22): 3066-3075, 2016

Anti hiv treatment recent advances in targeted drug development. Sande, M A And R K Root (Ed ) Contemporary Issues in Infectious Diseases, Vol 9 Treatment Of Serious Infections in The 1990s Xii+243p Churchill Livingstone, Inc : New York, New York, Usa; Edinburgh, Scotland, Uk Illus 149-160, 1992

Noninvasive assessment of tumor vasculature response to radiation-mediated, vasculature-targeted therapy using quantified power Doppler sonography: implications for improvement of therapy schedules. Journal of Ultrasound in Medicine 25(12): 1507-1517, 2006

Recent advances in ligand targeted therapy. Journal of Drug Targeting 20(1): 1-22, 2012

Recent advances in targeted therapy for glioblastoma. Expert Review of Neurotherapeutics 15(8): 935-946, 2016

Recent advances in the use of microspheres for targeted therapy. Drugs Under Experimental and Clinical Research 11(9): 633-640, 1985

Recent Advances in Targeted Therapy for Glioma. Current Medicinal Chemistry 24(13): 1365-1381, 2016

Recent advances in targeted therapy for Ewing sarcoma. F1000research 5, 2016

Recent advances in targeted therapy for renal cell carcinoma. Current Opinion in Urology 17(5): 331-336, 2007

Recent advances in the HER2 targeted therapy of gastric cancer. World Journal of Clinical Cases 3(1): 42-51, 2015

Recent advances in histone deacetylase targeted cancer therapy. Surgery Today 40(9): 809-815, 2011

VEGF-targeted therapy: therapeutic potential and recent advances. Oncologist 10(6): 382-391, 2005

Recent advances in antigen-targeted therapy in non-Hodgkin's lymphoma. Annals of Hematology 79(4): 167-174, 2000

Recent advances in targeted therapy of human myelogenous leukaemia. Expert Opinion on Therapeutic Targets 9(6): 1147-1163, 2005

Recent advances in cutaneous melanoma: towards a molecular model and targeted treatment. Australasian Journal of Dermatology 54(3): 163-172, 2014